Utah Medical Products Statistics
Share Statistics
Utah Medical Products has 3.39M shares outstanding. The number of shares has increased by -4.2% in one year.
| Shares Outstanding | 3.39M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -1.45% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 3.16M |
| Failed to Deliver (FTD) Shares | 8 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 56.80K, so 1.67% of the outstanding shares have been sold short.
| Short Interest | 56.80K |
| Short % of Shares Out | 1.67% |
| Short % of Float | 1.8% |
| Short Ratio (days to cover) | 2.62 |
Valuation Ratios
The PE ratio is 18.41 and the forward PE ratio is null.
| PE Ratio | 18.41 |
| Forward PE | null |
| PS Ratio | 6.1 |
| Forward PS | null |
| PB Ratio | 2.39 |
| P/FCF Ratio | 14.15 |
| PEG Ratio | n/a |
Enterprise Valuation
Utah Medical Products Inc. has an Enterprise Value (EV) of 213.11M.
| EV / Earnings | 12.81 |
| EV / Sales | 4.24 |
| EV / EBITDA | 8.61 |
| EV / EBIT | 12.7 |
| EV / FCF | 9.85 |
Financial Position
The company has a current ratio of 22.56, with a Debt / Equity ratio of 0.
| Current Ratio | 22.56 |
| Quick Ratio | 20.53 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.13% and return on capital (ROIC) is 10.8%.
| Return on Equity (ROE) | 0.13% |
| Return on Assets (ROA) | 0.12% |
| Return on Capital (ROIC) | 10.8% |
| Revenue Per Employee | 297.18K |
| Profits Per Employee | 98.43K |
| Employee Count | 169 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 2.11 |
Taxes
| Income Tax | 3.45M |
| Effective Tax Rate | 0.17 |
Stock Price Statistics
The stock price has increased by -22.76% in the last 52 weeks. The beta is 0.08, so Utah Medical Products 's price volatility has been higher than the market average.
| Beta | 0.08 |
| 52-Week Price Change | -22.76% |
| 50-Day Moving Average | 65.28 |
| 200-Day Moving Average | 67.46 |
| Relative Strength Index (RSI) | 39.14 |
| Average Volume (20 Days) | 21.66K |
Income Statement
In the last 12 months, Utah Medical Products had revenue of $50.22M and earned $16.64M in profits. Earnings per share was $4.57.
| Revenue | 50.22M |
| Gross Profit | 30.04M |
| Operating Income | 16.78M |
| Net Income | 16.64M |
| EBITDA | 24.75M |
| EBIT | 16.78M |
| Earnings Per Share (EPS) | 4.57 |
Balance Sheet
The company has $92.87M in cash and $295.00K in debt, giving a net cash position of $92.57M.
| Cash & Cash Equivalents | 92.87M |
| Total Debt | 295.00K |
| Net Cash | 92.57M |
| Retained Earnings | 138.34M |
| Total Assets | 129.69M |
| Working Capital | 98.22M |
Cash Flow
In the last 12 months, operating cash flow was $22.28M and capital expenditures -$639.00K, giving a free cash flow of $21.64M.
| Operating Cash Flow | 22.28M |
| Capital Expenditures | -639.00K |
| Free Cash Flow | 21.64M |
| FCF Per Share | 5.95 |
Margins
Gross margin is 59.81%, with operating and profit margins of 33.4% and 33.12%.
| Gross Margin | 59.81% |
| Operating Margin | 33.4% |
| Pretax Margin | 40% |
| Profit Margin | 33.12% |
| EBITDA Margin | 49.28% |
| EBIT Margin | 33.4% |
| FCF Margin | 43.09% |
Dividends & Yields
UTMD pays an annual dividend of $1.22, which amounts to a dividend yield of 1.92%.
| Dividend Per Share | $1.22 |
| Dividend Yield | 1.92% |
| Dividend Growth (YoY) | 1.67% |
| Payout Ratio | 28.5% |
| Earnings Yield | 7.26% |
| FCF Yield | 10.14% |
Analyst Forecast
Currently there are no analyst rating for UTMD.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Mar 22, 1993. It was a forward split with a ratio of 3:2.
| Last Split Date | Mar 22, 1993 |
| Split Type | forward |
| Split Ratio | 3:2 |
Scores
| Altman Z-Score | 26.81 |
| Piotroski F-Score | 6 |